Stocks and Investing Stocks and Investing
Fri, January 4, 2019
Thu, January 3, 2019

Jason Gerberry Upgraded (TEVA) to Strong Buy on, Jan 3rd, 2019


Published on 2024-10-26 11:29:57 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy on, Jan 3rd, 2019.

Jason has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018
  • Tim Chiang of "BTIG" Upgraded from Strong Sell to Hold on, Monday, September 17th, 2018
  • Vamil Divan of "Credit Suisse" Maintained at Hold with Increased Target to $26 on, Monday, September 17th, 2018


These are the ratings of the 3 analyists that currently disagree with Jason


  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018
  • Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018
  • Irina Rivkind Koffler of "Mizuho" Maintained at Strong Buy with Increased Target to $29 on, Monday, September 17th, 2018

Contributing Sources